Samir Mukundray Dalia, MD | Oncology ...

Dr. Samir Dalia, MD

Claim this profile

Mercy Research Joplin

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
13 drugs studied

Area of expertise

1

Lung Cancer

Samir Dalia, MD has run 5 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
BRAF negative
ROS1 negative
2

Non-Small Cell Lung Cancer

Samir Dalia, MD has run 5 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage IV
BRAF negative
ROS1 negative

Affiliated Hospitals

Image of trial facility.

Mercy Research Joplin

Image of trial facility.

Mercy Clinic Oncology And Hematology - Joplin

Clinical Trials Samir Dalia, MD is currently running

More about Samir Dalia, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Samir Dalia, MD has experience with

  • Pembrolizumab
  • N-803
  • Pemetrexed
  • Carboplatin
  • Nab-paclitaxel
  • Nivolumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Samir Dalia, MD specialize in?

Is Samir Dalia, MD currently recruiting for clinical trials?

Are there any treatments that Samir Dalia, MD has studied deeply?

What is the best way to schedule an appointment with Samir Dalia, MD?

What is the office address of Samir Dalia, MD?

Is there any support for travel costs?